Lv5
950 积分 2021-02-19 加入
FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer
1天前
已完结
抗肿瘤药物申报联合用药早期临床试验的考虑
1天前
已完结
Second-line treatment outcomes after progression from first-line chemotherapy plus immunotherapy in patients with advanced non-small cell lung cancer
14天前
已完结
Discovery of novel pyrazole derivatives as potential anticancer agents in MCL
15天前
已完结
Design, synthesis, and biological evaluation of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitors
15天前
已完结
Discovery of 1-Amino-1H-imidazole-5-carboxamide Derivatives as Highly Selective, Covalent Bruton’s Tyrosine Kinase (BTK) Inhibitors
15天前
已完结
Recent development of BTK-based dual inhibitors in the treatment of cancers
15天前
已完结
Design, synthesis, and biological evaluation of pyrrolopyrimidine derivatives as novel Bruton's tyrosine kinase (BTK) inhibitors
29天前
已完结
Bruton’s tyrosine kinase (BTK) inhibitors: an updated patent review (2019-2024)
1个月前
已完结
Naquotinib exerts antitumor activity in activated B-cell-like diffuse large B-cell lymphoma
1个月前
已完结
皖公网安备34019202002308
